Stock Price Valeant: Step by Step, Out of the Pit
This article was written by Mingyue Liu, a Financial Analyst at I Know First.
Valeant Pharmaceuticals International: Step by Step, Out of the Pit
"Medicine really matured me as a person because, as a physician, you're obviously dealing with life and death issues, issues much more serious than what we're talking about in entertainment. You can't get more serious than life and death. And if you can handle that, you can handle anything." (Ken Jeong)Summary:
- Debt divestiture through debt redemption and non-core business sales
- Organic growth bolstered by potential launch of new drugs
- Other tailwinds that may weigh on the company's growth
